Dishman Carbogen Amcis Ltd.
| BSE: 540701 | Sector: Health care |
| NSE: DCAL | ISIN Code: INE385W01011 |
| BSE 00:00 | 24 May | 117.60 |
-1.10 (-0.93%) |
OPEN
120.25 |
HIGH
120.25 |
LOW
117.20 |
| NSE 00:00 | 24 May | 117.35 |
-1.40 (-1.18%) |
OPEN
120.00 |
HIGH
120.30 |
LOW
117.00 |
| OPEN | 120.25 |
| PREVIOUS CLOSE | 118.70 |
| VOLUME | 19033 |
| 52-Week high | 259.50 |
| 52-Week low | 109.45 |
| P/E | |
| Mkt Cap.(Rs cr) | 1,844 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dishman Carbogen Amcis Ltd. (DCAL) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 538.60 | -20.25 | -3.62 | 3112.91 |
| Cipla | 970.50 | -0.05 | -0.01 | 2468.28 |
| Dr Reddy's Labs | 4351.10 | 76.85 | 1.80 | 2186.40 |
| Sun Pharma.Inds. | 910.20 | -11.25 | -1.22 | 2139.70 |
| Divi's Lab. | 3662.05 | -235.50 | -6.04 | 1954.72 |
| Alkem Lab | 2932.40 | -52.65 | -1.76 | 1685.08 |
| Glenmark Pharma. | 394.55 | -8.85 | -2.19 | 1649.45 |
| Zydus Lifesci. | 368.15 | 5.75 | 1.59 | 1476.20 |
| Lupin | 601.15 | -17.25 | -2.79 | 1258.62 |
| Alembic Pharma | 756.35 | -4.05 | -0.53 | 1175.39 |
| Ipca Labs. | 955.60 | -21.45 | -2.20 | 1140.77 |
| Torrent Pharma. | 2592.50 | -23.60 | -0.90 | 1137.85 |
| Gland Pharma | 2871.65 | -109.30 | -3.67 | 997.01 |
| Laurus Labs | 567.15 | -5.40 | -0.94 | 956.11 |
| Sanofi India | 6587.80 | -48.65 | -0.73 | 944.40 |
| Abbott India | 18191.80 | 439.30 | 2.47 | 690.69 |
| Ajanta Pharma | 1699.30 | -26.80 | -1.55 | 675.64 |
| Wockhardt | 279.30 | -2.20 | -0.78 | 593.29 |
| Granules India | 280.75 | 0.60 | 0.21 | 552.78 |
| Pfizer | 4258.60 | -148.75 | -3.38 | 497.61 |
Quick Links for Dishman Carbogen Amcis:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
